Injectable Drug Delivery Devices-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Injectable Drug Delivery Devices-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Injectable Drug Delivery Devices industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Injectable Drug Delivery Devices 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Injectable Drug Delivery Devices worldwide and market share by regions, with company and product introduction, position in the Injectable Drug Delivery Devices market
Market status and development trend of Injectable Drug Delivery Devices by types and applications
Cost and profit status of Injectable Drug Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the global Injectable Drug Delivery Devices market as:
Global Injectable Drug Delivery Devices Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Injectable Drug Delivery Devices Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Conventional Drug Delivery Devices
Novel Drug Delivery Devices
Global Injectable Drug Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Others
Global Injectable Drug Delivery Devices Market: Manufacturers Segment Analysis (Company and Product introduction, Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Alkermes Inc.
Genentech Inc.
Bend Research
QLT Inc.
Endocyte
BIND Biosciences, Inc.
UCB Group (UCB)
Presage Bioscience
Polymer Factory
MicroCHIPS, Inc.
Pearl Therapeutics Inc.
Piedmont Pharmaceuticals
Zogenix, Inc.
Liquidia Technologies
Impax Laboratories Inc.
Boehringer Ingelheim
Crossject Medical Technology
Apogee Technology
Pulmatrix
Medicago
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Injectable Drug Delivery Devices-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Injectable Drug Delivery Devices industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Injectable Drug Delivery Devices 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Injectable Drug Delivery Devices worldwide and market share by regions, with company and product introduction, position in the Injectable Drug Delivery Devices market
Market status and development trend of Injectable Drug Delivery Devices by types and applications
Cost and profit status of Injectable Drug Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the global Injectable Drug Delivery Devices market as:
Global Injectable Drug Delivery Devices Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Injectable Drug Delivery Devices Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Conventional Drug Delivery Devices
Novel Drug Delivery Devices
Global Injectable Drug Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Others
Global Injectable Drug Delivery Devices Market: Manufacturers Segment Analysis (Company and Product introduction, Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Alkermes Inc.
Genentech Inc.
Bend Research
QLT Inc.
Endocyte
BIND Biosciences, Inc.
UCB Group (UCB)
Presage Bioscience
Polymer Factory
MicroCHIPS, Inc.
Pearl Therapeutics Inc.
Piedmont Pharmaceuticals
Zogenix, Inc.
Liquidia Technologies
Impax Laboratories Inc.
Boehringer Ingelheim
Crossject Medical Technology
Apogee Technology
Pulmatrix
Medicago
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF INJECTABLE DRUG DELIVERY DEVICES
1.1 Definition of Injectable Drug Delivery Devices in This Report
1.2 Commercial Types of Injectable Drug Delivery Devices
1.2.1 Conventional Drug Delivery Devices
1.2.2 Novel Drug Delivery Devices
1.3 Downstream Application of Injectable Drug Delivery Devices
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Development History of Injectable Drug Delivery Devices
1.5 Market Status and Trend of Injectable Drug Delivery Devices 2013-2023
1.5.1 North America Injectable Drug Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Injectable Drug Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Injectable Drug Delivery Devices in North America 2013-2017
2.2 Consumption Market of Injectable Drug Delivery Devices in North America by Regions
2.2.1 Consumption Volume of Injectable Drug Delivery Devices in North America by Regions
2.2.2 Revenue of Injectable Drug Delivery Devices in North America by Regions
2.3 Market Analysis of Injectable Drug Delivery Devices in North America by Regions
2.3.1 Market Analysis of Injectable Drug Delivery Devices in United States 2013-2017
2.3.2 Market Analysis of Injectable Drug Delivery Devices in Canada 2013-2017
2.3.3 Market Analysis of Injectable Drug Delivery Devices in Mexico 2013-2017
2.4 Market Development Forecast of Injectable Drug Delivery Devices in North America 2018-2023
2.4.1 Market Development Forecast of Injectable Drug Delivery Devices in North America 2018-2023
2.4.2 Market Development Forecast of Injectable Drug Delivery Devices by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Injectable Drug Delivery Devices in North America by Types
3.1.2 Revenue of Injectable Drug Delivery Devices in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Injectable Drug Delivery Devices in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Injectable Drug Delivery Devices in North America by Downstream Industry
4.2 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in Major Countries
4.2.1 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in United States
4.2.2 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in Canada
4.2.3 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in Mexico
4.3 Market Forecast of Injectable Drug Delivery Devices in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
5.1 North America Economy Situation and Trend Overview
5.2 Injectable Drug Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 6 INJECTABLE DRUG DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Injectable Drug Delivery Devices in North America by Major Players
6.2 Revenue of Injectable Drug Delivery Devices in North America by Major Players
6.3 Basic Information of Injectable Drug Delivery Devices by Major Players
6.3.1 Headquarters Location and Established Time of Injectable Drug Delivery Devices Major Players
6.3.2 Employees and Revenue Level of Injectable Drug Delivery Devices Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 INJECTABLE DRUG DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Alkermes Inc.
7.1.1 Company profile
7.1.2 Representative Injectable Drug Delivery Devices Product
7.1.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Alkermes Inc.
7.2 Genentech Inc.
7.2.1 Company profile
7.2.2 Representative Injectable Drug Delivery Devices Product
7.2.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Genentech Inc.
7.3 Bend Research
7.3.1 Company profile
7.3.2 Representative Injectable Drug Delivery Devices Product
7.3.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Bend Research
7.4 QLT Inc.
7.4.1 Company profile
7.4.2 Representative Injectable Drug Delivery Devices Product
7.4.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of QLT Inc.
7.5 Endocyte
7.5.1 Company profile
7.5.2 Representative Injectable Drug Delivery Devices Product
7.5.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Endocyte
7.6 BIND Biosciences, Inc.
7.6.1 Company profile
7.6.2 Representative Injectable Drug Delivery Devices Product
7.6.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of BIND Biosciences, Inc.
7.7 UCB Group (UCB)
7.7.1 Company profile
7.7.2 Representative Injectable Drug Delivery Devices Product
7.7.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of UCB Group (UCB)
7.8 Presage Bioscience
7.8.1 Company profile
7.8.2 Representative Injectable Drug Delivery Devices Product
7.8.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Presage Bioscience
7.9 Polymer Factory
7.9.1 Company profile
7.9.2 Representative Injectable Drug Delivery Devices Product
7.9.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Polymer Factory
7.10 MicroCHIPS, Inc.
7.10.1 Company profile
7.10.2 Representative Injectable Drug Delivery Devices Product
7.10.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of MicroCHIPS, Inc.
7.11 Pearl Therapeutics Inc.
7.11.1 Company profile
7.11.2 Representative Injectable Drug Delivery Devices Product
7.11.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Pearl Therapeutics Inc.
7.12 Piedmont Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Injectable Drug Delivery Devices Product
7.12.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Piedmont Pharmaceuticals
7.13 Zogenix, Inc.
7.13.1 Company profile
7.13.2 Representative Injectable Drug Delivery Devices Product
7.13.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Zogenix, Inc.
7.14 Liquidia Technologies
7.14.1 Company profile
7.14.2 Representative Injectable Drug Delivery Devices Product
7.14.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Liquidia Technologies
7.15 Impax Laboratories Inc.
7.15.1 Company profile
7.15.2 Representative Injectable Drug Delivery Devices Product
7.15.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Impax Laboratories Inc.
7.16 Boehringer Ingelheim
7.17 Crossject Medical Technology
7.18 Apogee Technology
7.19 Pulmatrix
7.20 Medicago
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
8.1 Industry Chain of Injectable Drug Delivery Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
9.1 Cost Structure Analysis of Injectable Drug Delivery Devices
9.2 Raw Materials Cost Analysis of Injectable Drug Delivery Devices
9.3 Labor Cost Analysis of Injectable Drug Delivery Devices
9.4 Manufacturing Expenses Analysis of Injectable Drug Delivery Devices
CHAPTER 10 MARKETING STATUS ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Injectable Drug Delivery Devices in This Report
1.2 Commercial Types of Injectable Drug Delivery Devices
1.2.1 Conventional Drug Delivery Devices
1.2.2 Novel Drug Delivery Devices
1.3 Downstream Application of Injectable Drug Delivery Devices
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Development History of Injectable Drug Delivery Devices
1.5 Market Status and Trend of Injectable Drug Delivery Devices 2013-2023
1.5.1 North America Injectable Drug Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Injectable Drug Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Injectable Drug Delivery Devices in North America 2013-2017
2.2 Consumption Market of Injectable Drug Delivery Devices in North America by Regions
2.2.1 Consumption Volume of Injectable Drug Delivery Devices in North America by Regions
2.2.2 Revenue of Injectable Drug Delivery Devices in North America by Regions
2.3 Market Analysis of Injectable Drug Delivery Devices in North America by Regions
2.3.1 Market Analysis of Injectable Drug Delivery Devices in United States 2013-2017
2.3.2 Market Analysis of Injectable Drug Delivery Devices in Canada 2013-2017
2.3.3 Market Analysis of Injectable Drug Delivery Devices in Mexico 2013-2017
2.4 Market Development Forecast of Injectable Drug Delivery Devices in North America 2018-2023
2.4.1 Market Development Forecast of Injectable Drug Delivery Devices in North America 2018-2023
2.4.2 Market Development Forecast of Injectable Drug Delivery Devices by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Injectable Drug Delivery Devices in North America by Types
3.1.2 Revenue of Injectable Drug Delivery Devices in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Injectable Drug Delivery Devices in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Injectable Drug Delivery Devices in North America by Downstream Industry
4.2 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in Major Countries
4.2.1 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in United States
4.2.2 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in Canada
4.2.3 Demand Volume of Injectable Drug Delivery Devices by Downstream Industry in Mexico
4.3 Market Forecast of Injectable Drug Delivery Devices in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
5.1 North America Economy Situation and Trend Overview
5.2 Injectable Drug Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 6 INJECTABLE DRUG DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Injectable Drug Delivery Devices in North America by Major Players
6.2 Revenue of Injectable Drug Delivery Devices in North America by Major Players
6.3 Basic Information of Injectable Drug Delivery Devices by Major Players
6.3.1 Headquarters Location and Established Time of Injectable Drug Delivery Devices Major Players
6.3.2 Employees and Revenue Level of Injectable Drug Delivery Devices Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 INJECTABLE DRUG DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Alkermes Inc.
7.1.1 Company profile
7.1.2 Representative Injectable Drug Delivery Devices Product
7.1.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Alkermes Inc.
7.2 Genentech Inc.
7.2.1 Company profile
7.2.2 Representative Injectable Drug Delivery Devices Product
7.2.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Genentech Inc.
7.3 Bend Research
7.3.1 Company profile
7.3.2 Representative Injectable Drug Delivery Devices Product
7.3.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Bend Research
7.4 QLT Inc.
7.4.1 Company profile
7.4.2 Representative Injectable Drug Delivery Devices Product
7.4.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of QLT Inc.
7.5 Endocyte
7.5.1 Company profile
7.5.2 Representative Injectable Drug Delivery Devices Product
7.5.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Endocyte
7.6 BIND Biosciences, Inc.
7.6.1 Company profile
7.6.2 Representative Injectable Drug Delivery Devices Product
7.6.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of BIND Biosciences, Inc.
7.7 UCB Group (UCB)
7.7.1 Company profile
7.7.2 Representative Injectable Drug Delivery Devices Product
7.7.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of UCB Group (UCB)
7.8 Presage Bioscience
7.8.1 Company profile
7.8.2 Representative Injectable Drug Delivery Devices Product
7.8.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Presage Bioscience
7.9 Polymer Factory
7.9.1 Company profile
7.9.2 Representative Injectable Drug Delivery Devices Product
7.9.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Polymer Factory
7.10 MicroCHIPS, Inc.
7.10.1 Company profile
7.10.2 Representative Injectable Drug Delivery Devices Product
7.10.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of MicroCHIPS, Inc.
7.11 Pearl Therapeutics Inc.
7.11.1 Company profile
7.11.2 Representative Injectable Drug Delivery Devices Product
7.11.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Pearl Therapeutics Inc.
7.12 Piedmont Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Injectable Drug Delivery Devices Product
7.12.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Piedmont Pharmaceuticals
7.13 Zogenix, Inc.
7.13.1 Company profile
7.13.2 Representative Injectable Drug Delivery Devices Product
7.13.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Zogenix, Inc.
7.14 Liquidia Technologies
7.14.1 Company profile
7.14.2 Representative Injectable Drug Delivery Devices Product
7.14.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Liquidia Technologies
7.15 Impax Laboratories Inc.
7.15.1 Company profile
7.15.2 Representative Injectable Drug Delivery Devices Product
7.15.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Impax Laboratories Inc.
7.16 Boehringer Ingelheim
7.17 Crossject Medical Technology
7.18 Apogee Technology
7.19 Pulmatrix
7.20 Medicago
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
8.1 Industry Chain of Injectable Drug Delivery Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
9.1 Cost Structure Analysis of Injectable Drug Delivery Devices
9.2 Raw Materials Cost Analysis of Injectable Drug Delivery Devices
9.3 Labor Cost Analysis of Injectable Drug Delivery Devices
9.4 Manufacturing Expenses Analysis of Injectable Drug Delivery Devices
CHAPTER 10 MARKETING STATUS ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
